SCHEMBL7170261

SCHEMBL7170261

Cc1ccccc1-c1c(C2CCCC2)n[nH]c1N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPHA4 P54764 1/20 0.43
▸ FFAR2 O15552 4/20 0.37
▸ S1PR1 P21453 1/20 0.37
▸ S1PR5 Q9H228 1/20 0.37
▸ PIK3CD O00329 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ PRKDC P78527 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ NFKB1 P19838 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ NFKB2 Q00653 1/20 0.35
▸ RELA Q04206 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HEXA P06865 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20837070 0.72 MAPK1 (0.43) HPGDNFKB1RAB9ANFKB2RELA
SCHEMBL10960154 0.71 HRH2 (0.34) FFAR2ALDH1A1
SCHEMBL7307418 0.70 HRH2 (0.37) FFAR2NPY5RALDH1A1
SCHEMBL21315881 0.69 HEXA (0.43) EPHA4PIK3CDPIK3CAPIK3CBPIK3CG
SCHEMBL1856310 0.65 EPHA4 (0.51) EPHA4FFAR2PIK3CDPIK3CAPIK3CB
SCHEMBL19941737 0.64 PDE5A (0.36) FFAR2ALDH1A1
SCHEMBL19941723 0.64 PDE5A (0.36) FFAR2ALDH1A1
SCHEMBL8902605 0.64 GABRA1 (0.39) S1PR1S1PR5TSHRSMN1; SMN2ALDH1A1
SCHEMBL15020704 0.64 IKBKB (0.45) MAPTSMN1; SMN2NPSR1NOTUM
SCHEMBL5184422 0.63 BRD4 (0.34) USP2MAPTALOX15SMN1; SMN2GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004050650-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER PHARMACEUTICALS CORPORATION (US) 2004-06-17 — — WO disclosed
Send feedback